FDA snubs AbbVie's prospective Botox heir amid series of manufacturing-related CRLs

24th April 2026 Uncategorised 0

The FDA rejected two new products from AbbVie and Grace Therapeutics, citing manufacturing-related concerns.

More: FDA snubs AbbVie's prospective Botox heir amid series of manufacturing-related CRLs
Source: fierce